Flax Pond Capital’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$674K Buy
183,086
+3,000
+2% +$12.1K 0.48% 43
2026
Q2
$764K Buy
180,086
+3,950
+2% +$18.1K 0.53% 44
2026
Q1
$817K Buy
176,136
+2,503
+1% +$14.3K 0.66% 36
2025
Q4
$1.23M Buy
+173,633
New +$1.28M 0.91% 38

Other funds holding BCYC

Flax Pond Capital's BCYC Position: Q3 2026 in Review

Flax Pond Capital increased its Bicycle Therapeutics (BCYC) stake by 1.7% in Q3 2026, buying an estimated $12.1K and bringing the position to 183,086 shares worth $674K. The position accounts for 0.48% of the portfolio, ranked #43.

Flax Pond Capital first reported a position in BCYC in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.23M in Q4 2025. 90 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.

  • Flax Pond Capital held 183,086 shares of Bicycle Therapeutics worth $674K as of Q3 2026.
  • Flax Pond Capital bought 3,000 Bicycle Therapeutics shares in Q3 2026, an estimated $12.1K.
  • Bicycle Therapeutics made up 0.48% of Flax Pond Capital's portfolio in Q3 2026, its #43 holding.
  • Flax Pond Capital first reported a position in Bicycle Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Flax Pond Capital's Bicycle Therapeutics position peaked at $1.23M in Q4 2025.
  • 90 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.

Based on Flax Pond Capital's 13F filing for Q3 2026, filed 18 Nov 2026.